Company overview

Amylin Pharmaceuticals (Amylin) is engaged in the discovery, development and commercialization of potential drug candidates for the treatment of diabetes and obesity. The company primarily focuses on investigating the potential utility of new peptide hormone candidates for the treatment of psychiatric indications. It has two marketed products in its portfolio, namely, Byetta and Symlin, for the treatment of diabetes. Amylin primarily operates in the US and Germany.

The company is headquartered in San Diego, California and employed 1,900 people as of December 2007.

The company recorded revenues of $781 million during the financial year (FY) ended December 2007, an increase of 52.9% over FY2006. The increase was primarily attributable to the continued strong growth in the product sales of Byetta and Symlin. The operating loss of the company was $243 million during FY2007, as compared to an operating loss of $237 million in FY2006. The net loss was $211 million in FY2007, as compared to a net loss of $219 million in FY2006.

Key facts

NASDAQ ticker: AMLN

No. employees: 1900

Turnover: 780,997,000 (USD)

Financial year end: December

Summary

• Key facts
• Overview
• Business Description
• History
• Key Employees and Biographies
• Location and Subsidiaries
• Top Competitors
• Major Products and Services

SWOT Profiles

This SWOT analysis company profile is the essential source for top level data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Scope of this research

• Provides all the crucial company information required for business and competitor intelligence needs.
• Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams.
• Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Key reasons to purchase this research

• Support sales activities by understanding your customers' businesses better
• Qualify prospective partners and suppliers
• Keep fully up to date on your competitors' business structure, strategy and prospects
• Obtain the most up to date company information available